Wright Medical Group, Inc. (WMGI) launched a new product for surgical treatment of foot and ankle fractures, the ORTHOLOC Polyaxial Locked Plating System. The new product will be marketed in the U.S. by the company’s specialized foot and ankle sales force, with the full rollout expected in the first quarter of 2010. The product will be marketed in international markets by the company’s direct and distributor-based sales representatives.

The ORTHOLOC system is an advanced and comprehensive solution for treating common bone fractures of the foot and ankle. It comprises of three instruments and plating trays: implants, plates and screws, all of which incorporate Wright’s advanced ORTHOLOC polyaxial locking technology. Wright’s locked plating provides greater stability of the bone/plate construct over conventional non-locked plates. The new product also provides surgeons with greater flexibility in placing a locking screw.

The new product is the latest addition in Wright’s expanding product range for foot and ankle surgeries. This is expected to boost the company’s top-line. Wright Medical is a global orthopedic devices company specializing in the design, manufacture, and marketing of reconstructive joint devices and bio-orthopedic materials.

The orthopedic industry is highly competitive, and Wright Medical faces challenges from large players, such as Zimmer Holdings Inc. (ZMH), Stryker Corporation (SYK), Johnson & Johnson/De Puy (JNJ), Smith & Nephew plc. (SNN) and Biomet.
Read the full analyst report on “WMGI”
Read the full analyst report on “ZMH”
Read the full analyst report on “SYK”
Read the full analyst report on “JNJ”
Read the full analyst report on “SNN”
Zacks Investment Research